| 1,361 | O'NEILL, KELLY ANNMARIETTA, PA · 17547 | DISTRIBUTION · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,362 | STEIRER, JOSEPH PDURHAM, NC · 27709 | VACCINE KEY ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,363 | HOCH, JEFFREY SCOTTDURHAM, NC · 27709 | VACCINE FIELD VICE PRESIDENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,364 | WAGNER, JULIE MIDORIDURHAM, NC · 27709 | VACCINE ACCT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,365 | BULCHANDANI, ANILDURHAM, NC · 27709 | PRICING/REIMBURSEMENT - ANIL BULCHANDA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,366 | COSTELLO, JENNIFER B.DURHAM, NC · 27709 | FVP, ENTERPRISE INTEGRATED ACCOUNTS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,367 | ROBERTS, JACQUELINE ADURHAM, NC · 27709 | MARKET ACCESS ACCOUNT INTEGRATION DIRE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,368 | FANUTTI, JULIE ANNPHILADELPHIA, PA · 19112 | SALES AND/OR MARKETING TRAINING (ONCOL · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,369 | JEMERSON, ANTHONY LATROYDURHAM, NC · 27709 | DIRECTOR, NATIONAL ACCTS, VIIV · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,370 | ANDREWS, DARYLDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 1,371 | DEMELIA, HEATHERNORTH ATTLEBORO, MA | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | EMILYS LISTC00193433 | 2025-11-24 | $15 | Primary (P) | Filing 1950230 · amendedFEC filing ↗ |
| 1,372 | PARKER, DEBRA D.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |
| 1,373 | LOUGHLIN, CATHERINEDURHAM, NC · 27701 | VICE PRESIDENT, US SPECIALTY AND ONCOL · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |
| 1,374 | NIJINSKY, SONYA ALEXANDRA MOIRAPHILADELPHIA, PA · 19112 | INTERNAL QUALITY AUDIT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |
| 1,375 | CRUZ, CHRISTIAN OMARWASHINGTON, DC · 20004 | PUBLIC POLICY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |
| 1,376 | ANDERSON, CHARLES ALLENDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |
| 1,377 | BERGEY, AMANDA SCHROEDERPHILADELPHIA, PA · 19112 | PRODUCT STRATEGY & DEVELOPMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |
| 1,378 | CARDELLI, PAULDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |
| 1,379 | NEILSON, NICHOLAS JAMESDURHAM, NC · 27709 | PRICING/REIMBURSEMENT - NICHOLAS NEILS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |
| 1,380 | BROWN, BRENT WILLIAM GEORGEDURHAM, NC · 27709 | SALES FORCE EFFECTIVENESS (ONCOLOGY) · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $15 | Primary (P) | Filing 1928923FEC filing ↗ |